Loss of chemerin triggers bone remodeling in vivo and in vitro

Long Han,Yu Zhang,Shiwei Wan,Qingbo Wei,Wenbing Shang,Guichen Huang,Penghua Fang,Wen Min
DOI: https://doi.org/10.1016/j.molmet.2021.101322
IF: 8.568
2021-11-01
Molecular Metabolism
Abstract:ObjectiveIt was reported that chemerin as an adipocyte-secreted protein could regulate bone resorption and bone formation. However, the specific molecular and gene mechanism of the chemerin role is unclear.MethodsIn the present study, we investigated the effects of chemerin on bone remodeling in rarres2 knockout (Rarres2-/-) mice, and examined the role of chemerin as determinant of osteoblast and osteoclast differentiation in Mc3t3-E1 and Raw264.7 cell lines.ResultsThe results showed that the bone mineral density and volume score, the trabecular thickness, the weight and bone formation marker BALP increased, but Tb.Sp and bone resorption marker TRACP-5b decreased in Rarres2-/- mice. Furthermore, the mRNA and protein expression of biomarkers to osteoblast (β-catenin, RANKL and OPG) significantly increased, but to osteoclast (CTSK and RANK) decreased in Rarres2-/- mice. In vitro, chemerin markedly suppressed β-catenin and OPG, but increased RANKL, CTSK and RANK expression. Moreover, knockdown of chemerin using RNA interference inhibited osteoblastogenesis genes and enhanced osteoclastogenesis genes in Mc3t3-E1 and Raw264.7 cells.ConclusionsTaken together, these data suggest an inhibitive effect of chemerin on osteoblast differentiation and proliferation through inhibition of Wnt/β-catenin signaling, and a stimulative effect of chemerin on osteoclast differentiation and proliferation via activation of RANK signaling. The maintenance of low chemerin level may be a potential strategy to prevent and treat osteoporosis.
endocrinology & metabolism
What problem does this paper attempt to address?